BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31767580)

  • 1. How timely is access to palliative care medicines in the community? A mixed methods study in a UK city.
    Miller EJ; Morgan JD; Blenkinsopp A
    BMJ Open; 2019 Nov; 9(11):e029016. PubMed ID: 31767580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists: a forgotten resource for palliative care.
    Tait PA; Gray J; Hakendorf P; Morris B; Currow DC; Rowett DS
    BMJ Support Palliat Care; 2013 Dec; 3(4):436-43. PubMed ID: 24950524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency supply of prescription-only medicines to patients by community pharmacists: a mixed methods evaluation incorporating patient, pharmacist and GP perspectives.
    Morecroft CW; Mackridge AJ; Stokes EC; Gray NJ; Wilson SE; Ashcroft DM; Mensah N; Pickup GB
    BMJ Open; 2015 Jul; 5(7):e006934. PubMed ID: 26163029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to palliative care medicines in the community: An evaluation of practice and costs using case studies of service models in England.
    Campling N; Birtwistle J; Richardson A; Bennett MI; Meads D; Santer M; Latter S
    Int J Nurs Stud; 2022 Aug; 132():104275. PubMed ID: 35667146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do patients with cancer pain view community pharmacy services? An interview study.
    Edwards Z; Blenkinsopp A; Ziegler L; Bennett MI
    Health Soc Care Community; 2018 Jul; 26(4):507-518. PubMed ID: 29479766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pharmacist in community palliative care-a scoping review.
    Thrimawithana TR; Spence M; Lee M; Naysoe N; Hanna S; Yako G; Goma S; Stupans I; Lim CX
    Int J Pharm Pract; 2024 May; 32(3):194-200. PubMed ID: 38584472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative study using interviews and focus groups to explore the current and potential for antimicrobial stewardship in community pharmacy informed by the Theoretical Domains Framework.
    Jones LF; Owens R; Sallis A; Ashiru-Oredope D; Thornley T; Francis NA; Butler C; McNulty CAM
    BMJ Open; 2018 Dec; 8(12):e025101. PubMed ID: 30593557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance and uncertainty: community pharmacy responses to over the counter medicine abuse.
    Cooper R
    Health Soc Care Community; 2013 May; 21(3):254-62. PubMed ID: 23320510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the potential extended role of community pharmacy in the management of osteoarthritis: A multi-methods study with pharmacy staff and other healthcare professionals.
    Simkins J; Holden MA; Babatunde O; White S; Nicholls E; Long A; Dziedzic K; Chudyk A; Todd A; Walker C; Stanford C; Cottrell E; Edwards J; Healey EL; Cork T; Mallen C; O'Brien N
    Musculoskeletal Care; 2024 Mar; 22(1):e1873. PubMed ID: 38453169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needs assessment study for community pharmacy travel medicine services.
    Hind CA; Bond CM; Lee AJ; van Teijlingen ER
    J Travel Med; 2008; 15(5):328-34. PubMed ID: 19006506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Like doing a jigsaw with half the parts missing': community pharmacists and the management of cancer pain in the community.
    Savage I; Blenkinsopp A; Closs SJ; Bennett MI
    Int J Pharm Pract; 2013 Jun; 21(3):151-60. PubMed ID: 23418926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving community access to terminal phase medicines through the implementation of a 'Core Medicines List' in South Australian community pharmacies.
    Tait P; Horwood C; Hakendorf P; To T
    BMJ Support Palliat Care; 2020 Mar; 10(1):e4. PubMed ID: 28167655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to do when presented with a prescription from another European country: insight from a qualitative study of pharmacists in England.
    Knai C; Saliba V; Davies J; McKee M; Khoshaba B; Lago E; San Miguel L
    Int J Pharm Pract; 2014 Apr; 22(2):112-8. PubMed ID: 23849254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the community pharmacy in palliative care: a nationwide survey in Japan.
    Ise Y; Morita T; Maehori N; Kutsuwa M; Shiokawa M; Kizawa Y
    J Palliat Med; 2010 Jun; 13(6):733-7. PubMed ID: 20597706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHARMACEUTICAL CARE IN OPINION OF POLISH MEDICAL AND PHARMACEUTICAL STUDENTS: AN EXPLORATORY STUDY.
    Swieczkowski D; Merks P; Jaguszewski M; Siluk D
    Acta Pol Pharm; 2017 May; 74(3):1021-1030. PubMed ID: 29513973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.